Serous Ovarian Tumor: Clinical Trials

4 trials for Serous Ovarian Tumor, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Completed 1

Follow Serous Ovarian Tumor: new trials by email Literature Review of Serous Ovarian Tumor trials Research Report on Serous Ovarian Tumor

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study of Isoquercetin in People With Ovarian Cancer
Isoquercetin, Placebo - Ovarian Cancer, Epithelial Ovarian Cancer
Phase 2RecruitingMemorial Sloan Kettering Cancer Center902026-01-222026-09-15
Niraparib Rechallenge After Surgery in Ovarian Cancer Patients With Oligometastatic Progression
Niraparib oral tablets - Ovarian Cancer, Oligometastatic Disease
Phase 2RecruitingMedSIR302024-12-032026-04-22
Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study
Somatic and Germline BRCA1/2 Testing - Serous Ovarian Tumor, Endometrioid Carcinoma Ovary
CompletedCancer Trials Ireland2002019-03-222026-04-13
FUlvestrant in Gynecological Cancers That Are Potentially Hormone Sensitive: the FUCHSia Study
Fulvestrant - Endometrial Stromal Sarcoma, Adenosarcoma of Uterus
Phase 2CompletedFrederic Amant172019-03-132024-05-28

Narrower conditions

Ovarian Neoplasms (2)  ·  Adenosarcoma of the uterus (1)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Sarcoma, Endometrial Stromal (1)  ·  Sex Cord-Gonadal Stromal Tumors (1)

Broader conditions

Female Urogenital Diseases (4)  ·  Female Urogenital Diseases and Pregnancy Complications (4)  ·  Genital Diseases (4)  ·  Genital Diseases, Female (4)  ·  Genital Neoplasms, Female (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Urogenital Diseases (4)  ·  Urogenital Neoplasms (4)  ·  Adnexal Diseases (3)  ·  Endocrine Gland Neoplasms (2)  ·  Endocrine System Diseases (2)  ·  Gonadal Disorders (2)  ·  Neoplasms by Histologic Type (2)  ·  Ovarian Diseases (2)

Interventions

Diploidy (1)  ·  Fulvestrant (1)  ·  isoquercitrin (1)  ·  niraparib (1)

Sponsors

Cancer Trials Ireland (1)  ·  Frederic Amant (1)  ·  MedSIR (1)  ·  Memorial Sloan Kettering Cancer Center (1)

Countries

Belgium (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Spain (1)  ·  United States (1)

Top investigators

Jeffrey Zwicker, MD (1)  ·  Prof. Bryan Hennessy (1)

NIH funding

2017 (1)